Literature DB >> 596950

Blood hyperviscosity with reduced skin blood flow in scleroderma.

M A McGrath, R Peek, R Penny.   

Abstract

The vascular complications of scleroderma have previously been attributed to the progressive obliteration of small vessels. Our study was carried out to determine whether abnormalities of blood viscosity occur in this disease, thereby contributing to the ischaemic process. Blood viscosity was measured in 20 patients using a rotational viscometer. At a high rate of shear, blood hyperviscosity was found in 35% of the patients and at a low rate of shear, in 70%. In addition there was a significant increase in the plasma viscosity which implicates changes in plasma proteins (fibrinogen, immunoglobulins) as causing the hyperviscosity. Measurement of the hand blood flow by venous occlusion plethysmography showed reduced flow at 32 degrees , 27 degrees , and 20 degrees C. A unique finding was a delayed recovery of the blood flow after cooling. These observations suggest that the increased resistance to blood flow in skin affected by scleroderma may be caused by an interaction between the occlusive vascular lesion and blood hyperviscosity. In addition, blood flow patterns and hyperviscosity could help distinguish scleroderma from primary Raynaud's disease.

Entities:  

Mesh:

Year:  1977        PMID: 596950      PMCID: PMC1000165          DOI: 10.1136/ard.36.6.569

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  SOME FEATURES OF ANGIOGRAPHIC FINDINGS IN RHEUMATOID ARTHRITIS AND SCLERODERMA.

Authors:  P SOILA
Journal:  Acta Rheumatol Scand       Date:  1964

2.  Influence of flow properties of blood upon viscosity-hematocrit relationships.

Authors:  R E WELLS; E W MERRILL
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

3.  VISCOSITY OF NORMAL HUMAN BLOOD UNDER NORMOTHERMIC AND HYPOTHERMIC CONDITIONS.

Authors:  P W RAND; E LACOMBE; H E HUNT; W H AUSTIN
Journal:  J Appl Physiol       Date:  1964-01       Impact factor: 3.531

4.  Methods for the investigation of peripheral blood flow.

Authors:  A D GREENFIELD; R J WHITNEY; J F MOWBRAY
Journal:  Br Med Bull       Date:  1963-05       Impact factor: 4.291

5.  Effect of sympathectomy on the response to adrenaline of the blood vessels of the skin in man.

Authors:  R S DUFF
Journal:  J Physiol       Date:  1952-08       Impact factor: 5.182

Review 6.  On biorheology.

Authors:  A L Copley
Journal:  Biorheology       Date:  1973-06       Impact factor: 1.875

7.  Serologic alterations in scleroderma and sclerodermatomyositis.

Authors:  J A Clark; R K Winkelmann; L E Ward
Journal:  Mayo Clin Proc       Date:  1971-02       Impact factor: 7.616

8.  Peripheral ischaemia caused by blood hyperviscosity.

Authors:  M A McGarth; G D Tracy; R S Lord; R Penny
Journal:  Aust N Z J Surg       Date:  1973-09

9.  Clinical significance of blood viscosity.

Authors:  J A Dormandy
Journal:  Ann R Coll Surg Engl       Date:  1970-10       Impact factor: 1.891

10.  Paraproteinemia: blood hyperviscosity and clinical manifestations.

Authors:  M A McGrath; R Penny
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

View more
  9 in total

Review 1.  Raynaud's syndrome.

Authors:  E D Cooke; A N Nicolaides
Journal:  BMJ       Date:  1990-03-03

2.  A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.

Authors:  M I Jayson; C D Holland; A Keegan; K Illingworth; L Taylor
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

3.  Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?

Authors:  Bihter Senturk; Bahri Akdeniz; Mehmet Birhan Yilmaz; Buse Ozcan Kahraman; Burak Acar; Sadettin Uslu; Merih Birlik
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

4.  Haemorrheological response to plasma exchange in Raynaud's syndrome.

Authors:  A J Dodds; M J O'Reilly; C J Yates; L T Cotton; P T Flute; J A Dormandy
Journal:  Br Med J       Date:  1979-11-10

5.  Plasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes.

Authors:  I B Kovacs; M H Rustin; R H Thomas; C Ridler; S O Sowemimo-Coker; J D Kirby
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

6.  Systemic sclerosis: a collagen or microvascular disease?

Authors:  M I Jayson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-23

7.  A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.

Authors:  A Kahan; B Amor; C J Menkes
Journal:  Ann Rheum Dis       Date:  1985-01       Impact factor: 19.103

Review 8.  Systemic sclerosis--a microvascular disorder?

Authors:  M I Jayson
Journal:  J R Soc Med       Date:  1983-08       Impact factor: 18.000

Review 9.  Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis.

Authors:  Edward S Harris; Herbert J Meiselman; Patrick M Moriarty; Allan Metzger; Miroslav Malkovsky
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.